Experience and enlightenment of generic drug substitution promotion policy in drug use in typical foreign countries
10.3969/j.issn.1674-2982.2023.12.007
- VernacularTitle:域外典型国家药品使用环节仿制药替代促进政策的经验及启示
- Author:
Xiao-Yue REN
1
;
Jian-Zhou YAN
;
Rui-Lin DING
;
Rong SHAO
Author Information
1. 中国药科大学国家药物政策与医药产业经济研究中心 江苏南京 211198
- Keywords:
Substitution of generic drugs;
Clinical use;
Doctor-patient preferences;
International experience
- From:
Chinese Journal of Health Policy
2023;16(12):49-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective:From the link of drug use to improve China's generic drug substitution promotion policy to provide suggestions.Methods:Literature research method was used to explore the ideas and typical measures of promoting generic drug substitution in Europe,the United States,Japan and other countries.Combined with the existing problems in the process of generic drug substitution in China,specific suggestions were put forward to improve the promotion policy of generic drug substitution in the process of drug use in China.Results and conclusions:Through the experience research of Europe,the United States,Japan and other countries,it is found that typical countries outside the region have formed the idea of"accepting generic drugs-scientific and reasonable substitution-continuous feedback and improvement"in the process of promoting generic drug substitution.It is suggested that China incorporate the opinions of doctors and patients into the generic drug substitution decision-making,establish generic drug substitution rules based on risk,strengthen the real-world data research and monitoring and evaluation of generic drug substitution,strengthen the disclosure of generic drug information and policy publicity,further improve the promotion policy of generic drug substitution in the drug use process in China,and promote the alternative use of generic drugs.
